Business

Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026

MIAMI, March 12, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will report 2025 full year financial results and provide a business update on Tuesday, March 17, 2026 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 4:30 p.m. ET. Conference Call and Webcast Details:

articleLongeveron Inc.March 12, 20261/company/longeveron-llc/news/longeveron-to-report-2025-full-year-financial-results-and-host-conference-call-on-march-17-2026-8
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026

About this update from Longeveron Inc.

[{"type":"image","alt":"Longeveron","displaySize":"","headline":null,"caption":"Longeveron","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":56,"url":"https://media.zenfs.com/en/globenewswire.com/7020f3e4e4ad01a05af1150b74d0406a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.X2J.blw.0f9XkdGnRbwAQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/7020f3e4e4ad01a05af1150b74d0406a","width":300,"height":56}},"lazy":false},{"type":"text","content":"MIAMI, March 12, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will report 2025 full year financial results and provide a business update on Tuesday, March 17, 2026 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 4:30 p.m. ET.","length":463,"tagName":"p"},{"type":"text","content":"Conference Call and Webcast Details:","length":36,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"max-width:20%;width:20%;min-width:20%;vertical-align:top;","val":[{"type":"text","content":"Conference Call Number:","length":23,"tagName":"p","attribs":{}}]},{"style":"max-width:80%;width:80%;min-width:80%;vertical-align:top;","val":[{"type":"text","content":"1.877.407.0789","length":14,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Conference ID:","length":14,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"13758462","length":8,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Call meTM Feature:","length":18,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"Click Here","length":10,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Webcast:","length":8,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val...

More updates from Longeveron Inc.

Longeveron Inc.conference callThe Companybiotechnology companyfinancial marketsAbout Longeveron IncPediatric Dilated Cardiomyopathyinvestigational product